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Abstract
Cytolethal distending toxin (CDT) produced by Campylobacter jejuni comprises a heterotrimeric complex formed by CdtA,
CdtB, and CdtC. Among these toxin subunits, CdtA and CdtC function as essential proteins that mediate toxin binding to
cytoplasmic membranes followed by delivery of CdtB into the nucleus. The binding of CdtA/CdtC to the cell surface is
mediated by cholesterol, a major component in lipid rafts. Although the putative cholesterol recognition/interaction amino
acid consensus (CRAC) domain of CDT has been reported from several bacterial pathogens, the protein regions contributing
to CDT binding to cholesterol in C. jejuni remain unclear. Here, we selected a potential CRAC-like region present in the CdtC
from C. jejuni for analysis. Molecular modeling showed that the predicted functional domain had the shape of a
hydrophobic groove, facilitating cholesterol localization to this domain. Mutation of a tyrosine residue in the CRAC-like
region decreased direct binding of CdtC to cholesterol rather than toxin intermolecular interactions and led to impaired CDT
intoxication. These results provide a molecular link between C. jejuni CdtC and membrane-lipid rafts through the CRAC-like
region, which contributes to toxin recognition and interaction with cholesterol.
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Introduction
Campylobacter jejuni is a Gram-negative bacterium that commonly
causes diarrhea in humans worldwide [1]. C. jejuni-associated
enterocolitis is typically associated with a local acute inflammatory
response that involves intestinal tissue damage [2]. Several
bacterial virulence factors of C. jejuni, including adhesion
molecules, flagella, and cytotoxins, have been investigated for
their roles in host pathogenesis [3]. Although cytolethal distending
toxin (CDT) from C. jejuni has been characterized [4], the
molecular mechanisms underlying CDT involvement in C. jejuni-
induced host pathogenesis requires further investigation.
CDT is a bacterial genotoxin consisting of a heterotrimeric
complex comprising CdtA, CdtB, and CdtC [5]. CDT holotoxin,
which is produced by various important Gram-negative bacteria,
has been well characterized [6]. Several studies have shown that
CdtA and CdtC are essential for mediating toxin binding to the
cytoplasmic membrane of target cells [5,7,8]. Upon binding to the
cell membrane, CdtB is internalized into the cells and is further
translocated into the nucleus [9]. Irrespective of the bacterial
species, the nuclear-translocated CdtB contains type I deoxyribo-
nuclease activity that can cause double-strand DNA breakage
(DSB) followed by cell cycle arrest at G2/M [10]. These insights
into the biological function of the CDT holotoxin have identified
CDT as an essential factor for C. jejuni-induced pathogenesis in
host cells [11].
Increasing evidence has demonstrated that CdtA and CdtC
form a heterodimeric complex that enhances attachment of the
toxin to cell membranes [5,7,12]. The presence of a C-terminal
non-globular structure in CdtA and CdtC is important for toxin
assembly and attachment to the cell membrane [8]. Structural
studies have shown that CdtA and CdtC exhibit ricin-like lectin
structures [10], indicating that membrane glycoproteins contribute
to the binding of CDT to cells [13]. A recent study demonstrated
that both membrane carbohydrates and cholesterol play a critical
role in CDT binding to cultured cells [14]. As shown by several
studies, reduction in membrane cholesterol levels prevents CdtA/
CdtC from binding to target cells and results in attenuated CDT
intoxication [15,16]. In previous studies on toxin interactions with
cholesterol-rich microdomains, CdtC from Aggregatibacter actinomy-
cetemcomitans was found to contain a cholesterol recognition/
interaction amino acid consensus (CRAC) region [L/V(X)1–5
Y(X)1–5R/K] that is important for toxin binding and facilitating
endocytosis of CdtB [17]. These lines of evidence support the
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hypothesis that CdtA/CdtC might harbor a unique motif required
for toxin binding to cholesterol. Although putative sequences of C.
jejuni CdtA/CdtC required for binding to cultured cells have been
reported [7], the exact protein regions contributing to toxin
recognition and interaction with cholesterol have not yet been
determined. Our recent study has shown that cholesterol provides
a platform for C. jejuni CDT intoxication of cells [16]; however, the
molecular mechanism for the interaction of C. jejuni CdtA/CdtC
with cholesterol remains unknown.
In this study, we examined the potential CRAC-like region
present in CdtC from C. jejuni and functionally assessed this
candidate cholesterol-binding motif in CdtC. Mutational analysis
of the CRAC-like region showed that a tyrosine residue is essential
for CdtC membrane binding but not for toxin assembly. Our
results further indicated that a putative CRAC-like region is
present in C. jejuni CdtC, which contributes to the interaction with




Antibody against proliferating cell nuclear antigen (PCNA) was
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Anti-actin mouse monoclonal antibody was purchased from
Upstate Biotechnology (Lake Placid, NY). Alexa Fluor 488-
conjugated anti-mouse IgG was purchased from Invitrogen
(Carlsbad, CA). Antiserum against each CDT subunit was
prepared as described previously [16]. All other chemicals,
water-soluble cholesterol, and cholesterol depletion agent–meth-
yl-b-cyclodextrin (MbCD) were purchased from Sigma-Aldrich
(St. Louis, MO).
Construction of cdtCY81P and cdtCT163A?L164A mutants
cdtC ligated pET21d [16] was utilized as the template for
mutagenesis. Amino acid substitution was introduced into the cdtC
gene by site-directed mutagenesis. The forward and reverse
oligonucleotide primers used for amplification of cdtCY81P were
cdtC-F (59-GAACTTCCTTTTGGTCCTGTGCAATTTAC-39)
and cdtC-R (59-GTAAATTGCACAGGACC AAAAG-
GAAGTTC-39). The oligonucleotide primers used for generation
of cdtCT163A?L164A were forward: 59-CTTTGGAA-
TAGCCCCTTGCGCCGCAGATCCTATTTTTT-39 and re-
verse: 59-CTTTGGAA TAGCCCCTTGCGCCGCAGATCC-
TATTTTTT-39. Amplification of cdtC mutant was carried out
by using the QuikChange II site-directed mutagenesis system
(Stratagene, Santa Clara, CA). The mutation of cdtC was verified
by DNA sequencing.
Purification of CDT Subunits
Each recombinant His-tagged CDT subunit was cloned and
prepared as previously described [16]. Briefly, E. coli BL21-DE3
cells harboring CdtA, CdtB, CdtC or CdtCY81P expression
plasmids were induced by 0.5 mM of isopropyl b-D-thiogalacto-
pyranoside (IPTG) at 37uC for 3 h. The expressed His-tagged
CdtA, CdtB, and CdtC fusion proteins were purified by metal
affinity chromatography (Clontech, Palo-Alto, CA) and assessed by
SDS-PAGE and western blot.
SDS-PAGE and Western Blot Analyses
To test the reconstitution of CDT holotoxin, each recombinant
Cdt subunit (200 nM) was prepared and incubated at 37uC for
5 min allowed to assemble followed by incubation with cells [16].
CDT holotoxin-treated cells were then washed three times with
PBS and boiled in SDS-PAGE sample buffer for 5 min. The
samples were resolved by 12% SDS-PAGE and transferred onto
polyvinylidene difluoride membranes (Millipore, Billerica, MA).
The membranes were incubated with each antiserum against each
CDT subunit followed by incubated with horseradish peroxidase
(HRP)-conjugated secondary antibodies (Invitrogen). The proteins
of interest were detected using the ECL Western Blotting
Detection Reagents (GE Healthcare, Piscataway, NJ) and detected
using X-ray film (Kodak, Rochester, NY).
Structural simulation
The structure-based virtual docking of cholesterol for target
protein was described previously with a slight modification [18].
To build the cavity model of C. jejuni CdtC, the H. ducreyi CdtC
(Protein Data Bank Code: 1SR4 [10]) was employed as a template
using homology detection tool, SWISS-MODEL [19]. The initial
moiety of docked cholesterol into predicted CRAC-domain cavity
was carried out using GEMDOCK [20]. Energy minimization on
both the predicted CdtC model and the initial moiety were
prepared by Discovery Studio v3.0 (http://accelrys.com/
products/discoverystudio/). To further refine the initial docked
model through molecular dynamics, the final predicted docked
model was retrieved using CDOCKER with CHARMm force
field [21]. Structural figures were generated with the program
PyMol (http://www.pymol.org).
Dot Blot Analysis
The binding activities of CdtCwt and CdtCY81P to cholesterol
were analyzed by dot blot as described previously [18]. Briefly, the
polyvinylidene fluoride membranes (Millipore, Billerica, MA) were
prepared, and a series concentrations of water-soluble cholesterol
(0, 1.56, 3.13, 6.25, 12.5, 25, 50, 100, 200 mM) (Sigma-Aldrich)
were added onto membranes at the center of grid with vacuums.
The membranes were blocked by 3% BSA in PBS for 1 h followed
by incubated with 200 nM CdtCwt or CdtCY81P at room
temperature for 2 h. The membranes were washed with PBS
and probed with anti-CdtC antiserum and anti-mouse-HRP
antibody (Santa Cruz) at room temperature for 1 h, respectively.
The images were visualized by using Image Quant LAS-4000
(Fujifilm, Tokyo, Japan). The relative density of images was
quantified by using UN-SCAN-IT software (Silk Scientific
Corporation, Orem, UT).
Cell Culture
CHO-K1 cells (Chinese hamster ovary cells, CCL-61; Amer-
ican Type Culture Collection, Manassas, VA) and AGS cells
(human gastric adenocarcinoma cells, CRL 1739) were cultured in
F12 medium (HyClone, Logan, UT). COLO205 cells (human
colon adenocarcinoma cells, CCL-222) were cultured in RPMI
1640 medium (Invitrogen). All culture media were supplemented
with 10% complement-inactivated fetal bovine serum (HyClone,
Logan, UT) and penicillin/streptomycin (Invitrogen). The cells
were maintained at 37 uC in a humid atmosphere containing 5%
CO2.
Cell Binding Assay
CHO-K1 cells were exposed to 200 nM CDT holotoxin or an
individual CDT subunit at 4uC for 2 h. The cells were washed
twice with ice-cold PBS and fixed with 1% paraformaldehyde
(Sigma-Aldrich) for 30 min. The cells were washed three times,
and then incubated with anti-CdtB, or anti-CdtC antisera followed
by Alexa Fluor 488-conjugated anti-mouse IgG (Invitrogen). The
stained cells were subjected to cell cycle analysis using an
Interaction of C. jejuni CdtC with Cholesterol
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FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA).
The data were analyzed using Cell Quest software WinMDI
(Verity Software House). All samples were examined in triplicate
from three independent experiments.
Immunofluorescence
CHO-K1 cells were plated at a density of 56104 in six-well
plates and incubated for 24 h. Cells were exposed to 200 nM of
CDT subunit (CdtCwt or CdtCY81P) or CDT holotoxin (CdtABCwt
or CdtABCY81P, 200 nM each subunit) at 11uC. After 1 h, the
cells were washed and fixed in 1% paraformaldehyde (Sigma-
Aldrich) for 30 min followed by permeabilized with 0.1% Triton
X-100 for 30 min. Cells were incubated with and anti-CdtB, anti-
CdtC antisera and probed with Alexa Fluor 488-conjugated anti-
mouse IgG (Invitrogen). The prepared samples were then
observed by a confocal laser-scanning microscope (Zeiss LSM
510; Carl Zeiss, Go¨ttingen, Germany) with a 1006 objective (oil
immersion; aperture, 1.3).
Isolation of Nuclear Fraction
To explore the localization of CdtB in the nucleus of target cells,
CHO-K1 cells were exposed to 200 nM CdtABCwt or CdtAB-
CY81P holotoxin at 37uC for 4 h. The nuclear proteins were
isolated using a nuclear extraction kit (Pierce, Rockford, IL). All
protein concentrations were determined by colorimetric assay
using the Bio-Rad assay kit (Bio-Rad, Hercules, CA). The isolated
proteins (30 mg) from the nuclear fractions were then subjected to
western blot for analysis of CdtB localization.
Cell Cycle Analysis
Cells were treated with CdtABCwt or CdtABCY81P holotoxin for
24 h. Cells were harvested and fixed with ice-cold 70% ethanol for
2 h and stained with 20 mg/ml propidium iodide (Sigma-Aldrich)
containing 1 mg/ml RNase (Sigma-Aldrich) and 0.1% Triton X-
100 for 1 h. The stained cells were analyzed with an FACSCalibur
flow cytometer (Becton Dickinson, San Jose, CA). The data were
collected using 10,000 cells from each sample and analyzed using
Cell Quest software WinMDI (Verity Software House, Topsham,
ME). All samples were examined in triplicate from three
independent experiments.
Figure 1. Molecular modeling of the interaction of CdtCwt and cholesterol. (A) Schematic representation of a partial sequence of the CRAC-
like motif in wild-type and mutant CdtC. The numbers indicate the positions of the amino acid residues. The putative CRAC-like motifs are in boxes.
The amino acids in boldface indicate the residues targeted for substitution. (B) Structural model of cholesterol was in complex with putative CRAC of
CdtCwt. The cholesterol was shown in stick and colored in blue. The number of amino acids shown in CdtCwt directly interacted with the cholesterol-
binding sites. Oxygen atom localized in cholesterol and amino acids were shown in red. (C) Cholesterol showed hydrophobic interactions with L77,
P78, F79, G80, Y81, and V82 (boldface lines in green), and formed a hydrogen bond with V82 (dash line in green). Modeling simulation was performed
using PyMol, as described in the Materials and Methods.
doi:10.1371/journal.pone.0066202.g001
Figure 2. Binding of CdtC to cholesterol. (A) Direct binding of wild-
type CdtC (CdtCwt) or mutant CdtC (CdtCY81P) at various concentrations
of cholesterol were analyzed by dot blot. (B) The binding activities of
CdtC to cholesterol were quantified by densitometric analysis in 3
independent experiments. *, P,0.05 was considered as statistically
significant.
doi:10.1371/journal.pone.0066202.g002
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Figure 3. Effects of mutating the CRAC-like region on the binding of CdtC and CDT holotoxin to cells. CHO-K1 cells were treated with
200 nM of (A) CdtCwt, (B) CdtCY81P, (C) CdtABCwt, or (D) CdtABCY81P at 4uC for 2 h. The cells were washed and probed with control preimmune serum
(gray histograms) or antisera against CdtC (A, B) or CdtB (C, D) (white histograms), followed by staining with Alexa Fluor 488-conjugated anti-mouse
IgG. The binding activity was analyzed by flow cytometry. The numbers represent the mean channel fluorescence (MCF). The quantitative data
represent the mean and standard deviation values from 3 independent experiments (E, F). The asterisks indicate statistical significance (*P,0.05).
doi:10.1371/journal.pone.0066202.g003
Interaction of C. jejuni CdtC with Cholesterol
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Statistical Analysis
The Student’s t-test was used to calculate the statistical
significance of experimental results between two groups. A P
value of less than 0.05 was considered statistically significant.
Results
Generation and Characterization of Wild-type and
Mutant CDT Subunits
We recently demonstrated that CDT association with CHO-K1
cells requires intact cholesterol-rich microdomains [16]. A specific
conserved sequence, the CRAC motif [L/V(X)1–5Y(X)1–5R/K],
may contribute to the association of proteins with cholesterol [22].
To test this, we analyzed the amino acid sequence of CdtC, which
contained a putative CRAC-like motif (77LPFGY81VQFTNPK88)
(Fig. 1A). To assess whether this CRAC-like motif is required for
CdtC binding to lipid rafts and CDT intoxication of cells, we used
site-directed mutagenesis to construct a single residue-substituted
mutant. The tyrosine residue that plays an important role for
protein binding to cholesterol was thus replaced with a proline
residue (Y81P). The mutant and wild-type CDT subunits were
then subjected to SDS-PAGE (Fig. S1A) and western blot (Fig.
S1B) analyses. The purity and protein expression levels of
CdtCY81P were similar to those of CdtCwt. The integrity of the
toxin complex was then assessed by western blot. As shown in Fig.
S1C, both CdtCwt and CdtCY81P can be assembled stably with
other holotoxin elements.
The CRAC-like Motif is Essential for CdtC Binding to
Cholesterol
Structure-based virtual docking was employed to assess that
cholesterol binding to a CRAC sequence with 12 amino acid
residues (77LPFGYVQFTNPK88) of CdtCwt. Docking analysis
showed that the putative CRAC-like motif created a hydrophobic
groove, which enabled cholesterol to localize to it (Fig. 1B). The
best favored conformations of cholesterol were found by docking
and the surface represented the same helix. In addition, cholesterol
was found to be bound by hydrophobic interactions with the
protein residues L77, P78, F79, G80, Y81, and V82 and to form a
hydrogen bond with V82 which shown within hydrogen-bonding
distance of the cholesterol oxygen (2.8 A˚) (Fig. 1C). The results of
the molecular modeling showed that cholesterol fits into the
hydrophobic groove of the CRAC-like motif.
To further assess whether the CRAC-like motif played a role in
the CdtC-cholesterol interaction, the binding activities of CdtCwt
and CdtCY81P to cholesterol were analyzed by dot blot. As shown
in Fig. 2A, the binding activity of CdtCwt to immobilized
cholesterol was concentration dependent. In contrast, direct
binding to cholesterol was not detected for the CdtCY81P mutant
Figure 4. The role of the CRAC-like region in the association of
CdtC and holotoxin with cells. CHO-K1 cells were incubated with
mock medium alone or with 200 nM of CdtCwt, CdtCY81P, CdtABCwt, or
CdtABCY81P at 11uC for 1 h. The cells were probed with control
preimmune serum (mock) or antisera against CdtC (2nd and 3rd rows) or
CdtB (4th and 5th rows), followed by staining with Alexa Fluor 488-
conjugated anti-mouse IgG, and then analyzed by confocal microscopy.
Bar, 10 mm.
doi:10.1371/journal.pone.0066202.g004
Figure 5. Effects of mutations in the CRAC-like motif of CdtC on
CdtB nuclear localization. CHO-K1 cells were treated with mock
medium alone or with CdtABCwt or CdtABCY81P (200 nM each subunit)
at 37uC for 4 h. (A) Nuclear fractions were prepared and subjected to
western blot for analysis of CdtB. Proliferating cell nuclear antigen
(PCNA) was used as a loading control for the nuclear fraction of cell
lysates. (B) Expression levels of CdtB protein were analyzed using
scanning densitometry. The signals of CdtB/PCNA were expressed as
relative values. Statistical significance was evaluated using Student’s t-
test. *, P,0.05 was considered as statistically significant.
doi:10.1371/journal.pone.0066202.g005
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(Fig. 2B). These results indicated that the CRAC-like motif
mediates CdtC recognition and cholesterol binding.
The CRAC-like Motif is Required for the Association of
CDT with the Cell Membrane
We then analyzed whether the CRAC-like motif is important
for the association of CDT subunits with cell membranes. CHO-
K1 cells were incubated with CdtCwt or CdtCY81P for 2 h at 4uC
and were analyzed by flow cytometry for the presence of CDT
subunits on the cell membrane. As shown in Fig. 3A, CdtCwt was
associated with the cell membrane, and the MCF for anti-CdtC
was 93.5. However, upon exposure of cells to CdtCY81P, the MCF
for anti-CdtC reduced to 23.5 (Fig. 3B). We further tested whether
the CRAC-like motif mutant could affect the binding of holotoxin
to cells. The levels of MCF for anti-CdtB were 53.5 and 20.6 when
the cells were exposed to CdtABCwt and CdtABCY81P, respectively
(Fig. 3C, D). Notably, compared with the binding activities of
CdtCwt and CdtABCwt, the binding activities of both CdtCY81P
and CdtABCY81P to cell membranes were significantly lower
(Fig. 3E, F).
We used confocal microscopy to examine whether the binding
of CDT to cells was dependent on the CRAC-like motif in CdtC.
The cells were treated with CdtC (CdtCwt or CdtCY81P) or
holotoxin (CdtABCwt or CdtABCY81P), followed by probing with
preimmune serum and antisera against CdtB or CdtC. No signal
for CDT was detected in untreated cells (Fig. 4, first row), whereas
CdtCwt (green) apparently localized to the area around the plasma
membrane (Fig. 4, second row). In cells treated with CdtABCwt,
membrane distribution of CdtB was evident (Fig. 4, fourth row),
which was similar to that of cells treated with CdtCwt alone.
However, the intensity of detectable fluorescence for CdtC and
CdtB on the plasma membrane decreased when cells were treated
with CdtCY81P or CdtABCY81P (Fig. 4, third and fifth rows). These
results support our findings of CDT binding activity determined
by flow cytometry (Fig. 3), indicating that the CRAC-like motif is
critical for CdtC association with cells for CDT intoxication of the
cells.
Nuclear Delivery of CdtB Decreases in Cells Treated with
CdtABCY81P
We then examined whether the nuclear localization of CdtB
was dependent on the CRAC-like motif present in CdtC. The cells
were incubated with CdtABCwt or CdtABCY81P and subjected to
western blot analysis. As shown in Fig. 5, the nuclear localization
of CdtB dramatically decreased in cells treated with CdtABCY81P
when compared to the localization in cells treated with CdtABCwt.
These data suggested that CdtC associates with cell membranes
through the CRAC-like motif and that this association is
important for the delivery of CdtB into the nucleus.
Mutation of the CRAC-like Motif in CdtC Attenuates CDT
Intoxication of Cells
To determine whether the CRAC-like motif was required for
CDT intoxication of cells, we used flow cytometry to assess cell
cycle distributions. In the presence of CdtABCwt, 54% of cells
were arrested in G2/M (Fig. 6C). However, this cell cycle arrest
was attenuated upon treatment of cells with CdtABCY81P (Fig. 6D).
The cell cycle distributions were not changed in cells exposed to
CdtACwt and CdtACY81P, since the treatment was not contained
the toxin activity subunit–CdtB (Fig. 6E, F). In contrast, the cell
cycle arrest was significantly reduced in cells treated with
CdtBCY81P when compared to cells treated with CdtBCwt
(Fig. 6G, H). Pretreating cells with MbCD followed by exposure
to CdtABCwt dramatically decreased the proportion of cells
arrested in G2/M (Fig. 6I). These results supported the notion that
the CRAC-like motif contributes to the association of CdtC with
Figure 6. Attenuation of G2/M arrest by CdtABCY81P. CHO-K1 cells were incubated with (A) mock medium alone, 200 nM of (B) CdtAB, (C)
CdtABCwt, (D) CdtABCY81P, (E) CdtACwt, (F) CdtACY81P, (G) CdtBCwt, or (H) CdtBCY81P for 24 h, or (I) pretreated with 10 mM MbCD for 1 h followed by
incubation with 200 nM CdtABCwt for 24 h. The cells were stained with propidium iodide, and cell cycle distribution analyzed by flow cytometry. The
proportions of cells in the G0/G1, S, and G2/M phases of the cell cycle are shown at the right of each histogram. (J) The percentage of cells in G2/M
were calculated and plotted as intensity histograms. The results represent mean and standard deviation values from 3 independent experiments. *,
P,0.05 was considered as statistically significant.
doi:10.1371/journal.pone.0066202.g006
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membrane cholesterol, leading to the intoxication of CDT in
target cells.
We next investigated whether mutation of the CRAC-like motif
affected CDT-arrested cell cycles in other cell types. Two
gastrointestinal cell lines (AGS and COLO205 cells) were used
in this experiment. Cells were mock treated or treated with CDT
holotoxin (CdtABCwt or CdtABCY81P) and analyzed for the cell
cycle stage. As shown in Fig. 7, the proportion of cells
accumulating in G2/M in the 3 lines treated with CdtABCY81P
was significantly lower than that in the cells treated with
CdtABCwt. These results again demonstrated that the CRAC-like
motif present in CdtC is required for the association of CDT
holotoxin with cell membranes as well as for the intoxication of
target cells.
Discussion
Lipid rafts are membrane microdomains that contained mainly
cholesterol, sphingolipids, and phospholipids [23]. Membrane
rafts serve as a platform for several bacterial toxins binding to
target cells [24,25,26,27,28]. The most relevant example is
vacuolating cytotoxin A (VacA), one of the major virulence factors
secreted by Helicobacter pylori, which was demonstrated to exploit
cholesterol-rich microdomains for its assembly on cell membranes
and delivery into target cells [29]. Similarly, CDT produced by
Haemophilus ducreyi or A. actinomycetemcomitans was found to interact
with lipid rafts [15,30]. In agreement with these observations, our
recent study has shown that CDT from C. jejuni is associated with
lipid rafts [16]. These lines of evidence support the hypothesis that
cholesterol-rich microdomains may play a critical role in bacterial
toxin assembly on cell membranes and intracellular delivery, and
that these domains therefore amplify the signaling required for
intoxication [31].
Indeed, not all proteins that bind cholesterol harbor CRAC-
domains. For instance, the cholesterol-dependent cytolysin family
of toxins contains 2 amino acids (threonine and leucine) that are
responsible for interacting with cholesterol [32]. At the beginning
of this investigation, we first assessed whether the threonine-
leucine pair mediated the binding of CdtC to membrane
cholesterol. Our results show that mutations at the threonine
(T163) and leucine (L164) residues (CdtABCT163A?L164A) did not
affect CDT intoxication, as compared to treatment with
CdtABCwt (Figure S2), suggesting that this pair of amino acids
does not mediate the CdtC-cholesterol interaction.
In this study, the virtual docking simulation showed that C. jejuni
CdtC contains a CRAC-like motif (Fig. 1B). The 12 amino acid
residues LPFGYVQFTNPK created a hydrophobic groove that
provided for hydrophobic interactions and hydrogen bonding with
cholesterol. In addition, mutation of this domain decreased the
cell-binding activity of CdtC. However, comparison with CdtCwt
showed that the interaction of CdtCY81P with CdtA and CdtB in
complex formation was not altered (Fig. S1C). This finding is due
to the fact that the CRAC-like domain does not extend to the
CdtC N- and C-terminal regions that contribute to the interaction
of CdtC with both CdtA and CdtB [8]. Taken together, our
findings have demonstrated that the CRAC-like region involved in
CdtC plays a critical role in toxin binding to membrane
cholesterol and not in intermolecular interactions between toxin
subunits.
Our results for the dot blot analysis showed that CdtCY81P did
not bind to immobilized cholesterol (Fig. 2A). In addition, our data
further demonstrated that cell cycle arrest was significantly lower
in cells treated with CdtABCY81P or CdtBCY81P than in cells
treated with CdtABCwt or CdtBCwt (Fig. 6). These results are
supported by the functional analysis of CdtC from A. actinomyce-
temcomitans [33] and Haemophilus parasuis [34], indicating that CdtC
contains a CRAC-like region that is important for cholesterol
binding. However, the binding activity of CdtCY81P to the cell
surface did not completely abolished, as shown by our flow
cytometry and confocal microscopy analyses (Fig. 3 and 4), which
suggests that CdtC binding to cell membranes is mediated not only
by cholesterol but also by other candidate receptors. Previous
studies on CDTs from E. coli and A. actinomycetemcomitans indicated
a critical role of membrane carbohydrates in toxin interactions
Figure 7. The role of the CRAC-like region in CDT intoxication
of cells. Cells from the indicated lines (A) CHO-K1, (B) AGS, and (C)
COLO205 were treated with mock medium, CdtABCwt, or CdtABCY81P
(200 nM each subunit) at 37uC for 24 h. Cell cycle distribution was
assessed using flow cytometry. (D) The percentage of cells in G2/M
were calculated and plotted as intensity histograms. The results
represent 3 independent experiments. The statistical significance of
the difference was analyzed using Student’s t-test (*P,0.05).
doi:10.1371/journal.pone.0066202.g007
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[13,35]. In addition, structure-based analysis has shown that CdtA
and CdtC from A. actinomycetemcomitans have similar structures
comprising 3 sets of beta-sheets that are homologous to the B-
chain of ricin and contain lectin repeats, indicating that
carbohydrates may serve as receptors for CDT [36]. However, a
recent study on cell intoxication by CDTs, which were isolated
from several bacterial species, demonstrated that glycolipids are
not required for CDT intoxication [14]. Although these reports
indicate a discrepant role for carbohydrates in membrane
association of CDTs, our results are supported by several lines
of evidence indicating that cholesterol is one of the candidate
receptors for C. jejuni CDT interactions. Further investigations are
required to identify the specific receptor(s) that mediate membrane
association with C. jejuni CDT.
Since the CDTs from different bacterial species have distinct
binding activities, they are thought to have divergent target-cell
preferences [14]. Although these CDTs originate from different
pathogens, hijacking of cholesterol-rich microdomains for toxin
function appears to be the universal mechanism underlying CDT
action [15,16,30]. In this study, we have demonstrated that CdtC
from C. jejuni contains a CRAC-like region that contributes to the
CdtC interaction with cholesterol. Furthermore, the mutation of a
tyrosine residue in the CRAC-like region impairs CdtC binding to
and inhibits its intoxication of target cells. Elucidation of the target
receptor for C. jejuni CDT would lead to better understanding of
the molecular mechanisms underlying bacterial pathogenesis in
host cells. The results from this study also shed light on the
discovery of a novel strategy for specifically inhibiting this toxin.
Supporting Information
Figure S1 Characterization of wild-type and mutant
CDT subunits from C. jejuni. (A) Each CDT subunit (2 mg/
ml) was analyzed by SDS-PAGE. (B) Western blot analysis of each
CDT subunit detected via antisera against CdtA, CdtB, or CdtC.
Molecular mass markers (kDa) are shown on the left. (C) In vitro
assay for the toxin assembly of CdtABCwt and CdtABCY81P at
25uC for 1 h, determined by western blot.
(TIF)
Figure S2 Threonine (T163) and leucine (L164) of CdtC
are not required for CDT intoxication. CHO-K1 cells were
treated with (A) mock medium alone, (B) CdtABCwt, and (C)
CdtABCT163A?L164A (200 nM each subunit) for 24 h. The treated
cells were stained with propidium iodide, and the cell cycle
distribution was analyzed by flow cytometry. The proportions of
cells in the G0/G1, S, and G2/M phases of the cell cycle are
shown at the right of each histogram.
(TIF)
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